DIA
VRTX icon

Denver Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Denver Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,637
Closed -$1.26M – 664
2014
Q4 		$1.26M Buy
10,637
+3,006
+39% +$339K 0.04% 335
2014
Q3 		$857K Buy
+7,631
New +$727K 0.03% 362

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Denver Investment Advisors's VRTX Position: Q1 2015 in Review

Denver Investment Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q1 2015, closing a stake of 10,637 shares — an estimated $1.26M sold.

Denver Investment Advisors first reported a position in VRTX in Q3 2014 and held it in 2 quarters. The position peaked at $1.26M in Q4 2014. 479 funds tracked by Wall St. Rank hold VRTX as of Q1 2015.

  • Denver Investment Advisors reported no remaining Vertex Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 10,637 Vertex Pharmaceuticals shares in Q1 2015, an estimated $1.26M.
  • Denver Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Denver Investment Advisors's Vertex Pharmaceuticals position peaked at $1.26M in Q4 2014.
  • 479 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2015.

Based on Denver Investment Advisors's 13F filing for Q1 2015, filed 14 May 2015.